Drug intelligence / Profile preview

Jianzhong Qushi Formula

Development stage: Phase 3
Lead developer: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Administration: Oral

Overview

Jianzhong Qushi Formula is a traditional Chinese herbal medicine formula that appears to be used in clinical research for treating chronic recurrent respiratory infections (RRI). In traditional Chinese medicine theory, "Qushi" (祛湿) typically refers to "dispelling dampness," while "Jianzhong" (健中) refers to "strengthening the middle," which often relates to supporting digestive function and the spleen/stomach system. The formula is administered as a liquid preparation, with dosing typically 100ml per dose, taken twice daily before breakfast and after dinner, for a treatment period of 28 days.

Other names: Jianzhong Qushi

Beyond the preview

Go deeper on Jianzhong Qushi Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianzhong Qushi Formula.

Explore the full profile